Clinical Trial Update: Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a combination of etoposide, oxaliplatin, and capecitabine in advanced hepatocellular carcinoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Capecitabine (capecitabine)
• Etoposide (Etoposide)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: TERMINATED